All your MA & HTA needs in one place.

About us

Find out more about our history, values and Team.
Explore

Offer

See how we turn clinical data into market access strategies.
Explore

Publications

Read our latest publications.
Explore

Team

MAHTA is first and foremost about people who are dedicated to their work and constantly improving their knowledge, skills and competence.

Meet our team

Partnership

The reason for our immense pride, but also the measurable effect of our daily work, is increased access to effective forms of treatment and improve the quality of life of patients worldwide.

Explore

Bespoke solutions

We support the companies we work with at all stages of the reimbursement process. We offer knowledge, experience and a professional, flexible approach so that the solutions we propose are appropriate, effective and efficient.

Explore

in numbers

400

Over 400

successfully completed

reimbursement processes.

covering HTA.

40

Cooperation with over

40 renowned

specialists from various

areas of expertise.

50

Over 50 international processes successfully implemented.

News

Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland.

We are excited to share that the abstract entitled “Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland’’, developed by the MAHTA Team, will be presented at the ISPOR Europe 2025 conference in Glasgow.
Explore

MAHTA is proud to announce its role as a content partner for the 12th Scientific Conference, held under the distinguished patronage of JHPOR.

We are pleased to announce that MAHTA is a content partner of the 12th Scientific Conference under the patronage of the renowned Journal of Health Policy and Outcomes Research.
Explore

Merry Christmas and a Happy New Year.

Merry Christmas and a Happy New Year!
Explore

Publications

Matching‑Adjusted Indirect Comparison of Osilodrostat Versus Metyrapone for the Treatment of Cushing’s Syndrome

Hickey C., Gueron B., Schmidt F., Tyas E., Binowski G., Pivonello R.
Open

Budget Impact Analysis of Risdiplam in the Treatment of Newborn Spinal Muscular Atrophy Patients in Poland

Strachota S., Malysiak-Szpond S., Binowski G., Książek P., Sutherland C.S., Pruszko C.
Open

Cost-Effectiveness of Glycopyrronium Bromide Oral Solution for the Management of Severe Sialorrhea in Children With Cerebral Palsy in Poland

Łabęcka D., Binowski G., Książek P., Rynkiewicz S., Pruszko C.
Open